PsiOxus

PsiOxus doubles-down with BMS in $936M deal

PsiOxus Therapeutics has signed a second agreement with Bristol-Myers Squibb (BMS), this time for worldwide rights to its 'armed' oncolytic virus NG-348, currently in the preclinical research phase.

By Juliet Preston

A Data-Driven Guide to Patient Access Success

A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.

By Relatient

How PDPM Optimization Improves Facility Financial Performance

Transitioning to PDPM models significantly shifted the healthcare industry. By replacing the RUG system, healthcare providers cut waste and more accurately reflect the care each patient received.

By Medrina

How to Improve Employee Benefits While Reducing Insurance Costs

Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost.

By The Difference Card